Skip to main content
SpringerLink
Log in

Proton pump inhibitors and the risk of pancreatic cancer

  • Letter to the Editor
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Brusselaers N, Sadr-Azodi O, Engstrand L. Long-term proton pump inhibitor usage and the association with pancreatic cancer in Sweden. J Gastroenterol. 2020;55:453–61.

    Article  CAS  Google Scholar 

  2. Lai S-W. Proton pump inhibitors and the risk of pancreatic cancer. Journal of gastroenterology. 2021:In press.

  3. Pottegård A, Broe A, Hallas J, et al. Use of proton-pump inhibitors among adults: a Danish nationwide drug utilization study. Ther Adv Gastroenterol. 2016;9:671–8.

    Article  Google Scholar 

  4. Brusselaers N, Wahlin K, Engstrand L, et al. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden. BMJ Open. 2017;7:e017739.

    Article  Google Scholar 

  5. Matuz M, Benkő R, Engi Z, et al. Use of proton pump inhibitors in Hungary: mixed-method study to reveal scale and characteristics. Front Pharmacol. 2020;11:552102.

    Article  CAS  Google Scholar 

  6. Lassalle M, Le Tri T, Bardou M, et al. Use of proton pump inhibitors in adults in France: a nationwide drug utilization study. Eur J Clin Pharmacol. 2020;76:449–57.

    Article  CAS  Google Scholar 

  7. Halfdanarson OO, Pottegard A, Bjornsson ES, et al. Proton-pump inhibitors among adults: a nationwide drug-utilization study. Therap Adv Gastroenterol. 2018;11:1756284818777943.

    Article  Google Scholar 

  8. Savarino V, Marabotto E, Zentilin P, et al. Proton pump inhibitors: use and misuse in the clinical setting. Exp Rev Clin Pharmacol. 2018;11:1123–34.

    Article  CAS  Google Scholar 

  9. Brusselaers N, Engstrand L, Lagergren J. PPI use and oesophageal cancer: what if the results are true? Cancer Epidemiol. 2018;54:139–40.

    Article  Google Scholar 

  10. Xie Y, Bowe B, Yan Y, et al. Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study. BMJ (Clinical research ed). 2019;365:l1580.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Microbiology, Tumor and Cell Biology, Centre for Translational Microbiome Research, Karolinska Institutet, Karolinska Hospital, Biomedicum A8, Solnavägen 9, 171 65, Stockholm, Sweden

    Nele Brusselaers & Lars Engstrand

  2. Global Health Institute, Antwerp University, Antwerpen, Belgium

    Nele Brusselaers & Lars Engstrand

  3. Department of Head and Skin, Faculty of Medicine, Ghent University, Ghent, Belgium

    Nele Brusselaers

  4. Unit of Surgery, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden

    Omid Sadr-Azodi

  5. Department of Surgery, St Göran Hospital, Stockholm, Sweden

    Omid Sadr-Azodi

Authors
  1. Nele Brusselaers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Omid Sadr-Azodi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lars Engstrand
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nele Brusselaers.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brusselaers, N., Sadr-Azodi, O. & Engstrand, L. Proton pump inhibitors and the risk of pancreatic cancer. J Gastroenterol 56, 295–296 (2021). https://doi.org/10.1007/s00535-021-01761-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-021-01761-8

Search

Navigation